Page last updated: 2024-08-22

trimetazidine and ubiquinone

trimetazidine has been researched along with ubiquinone in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (11.11)	18.2507
2000's	1 (11.11)	29.6817
2010's	6 (66.67)	24.3611
2020's	1 (11.11)	2.80

Authors

Authors	Studies
Iliceto, S; Marangelli, V; Rizzon, P	1
Hauet, T; Morin, D; Spedding, M; Tillement, J	1
Simonenko, VB; Stepaniants, OS; Teslia, AN	1
Amaral, N; Okonko, DO	1
Fischer, T	1
Figtree, G; Ma, A; Shao, L; Zhang, P	1
Chen, F; Jin, Y; Liu, F; Lu, J; Xiao, B; Yang, X; Zhang, J	1
Zhao, L	1
Küçük, M; Öncel, CR	1

Reviews

4 review(s) available for trimetazidine and ubiquinone

Article	Year
Metabolic approach to myocardial ischemia: a novel therapeutic strategy for patients with coronary artery disease? Cardiologia (Rome, Italy), 1995, Volume: 40, Issue:10 Topics: Acetanilides; Carnitine; Clinical Trials as Topic; Coenzymes; Coronary Disease; Enzyme Inhibitors; Humans; Myocardial Ischemia; Piperazines; Ranolazine; Superoxide Dismutase; Trimetazidine; Ubiquinone; Vasodilator Agents	1995
Mitochondria as target for antiischemic drugs. Advanced drug delivery reviews, 2001, Jul-02, Volume: 49, Issue:1-2 Topics: Acetanilides; Animals; Antioxidants; Coenzymes; Drug Delivery Systems; Enzyme Inhibitors; Humans; Ion Channels; Membrane Proteins; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Piperazines; Potassium Channels; Ranolazine; Reperfusion Injury; Sodium-Calcium Exchanger; Trimetazidine; Ubiquinone; Vasodilator Agents	2001
Metabolic abnormalities of the heart in type II diabetes. Diabetes & vascular disease research, 2015, Volume: 12, Issue:4 Topics: Antioxidants; Cardiovascular Agents; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Energy Metabolism; Fatty Acids; Glucose; Humans; Mitochondria, Heart; Myocardium; Organophosphorus Compounds; Oxidative Phosphorylation; Oxidative Stress; Perhexiline; Ranolazine; Trimetazidine; Ubiquinone	2015
[Pharmacological therapy of age-related macular degeneration based on etiopathogenesis]. Orvosi hetilap, 2015, Nov-15, Volume: 156, Issue:46 Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Aspirin; Bosentan; Dietary Supplements; Docosahexaenoic Acids; Eicosapentaenoic Acid; Folic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infliximab; Lutein; Macular Degeneration; Melatonin; PPAR gamma; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System; Resveratrol; Stilbenes; Sulfonamides; Trimetazidine; Tumor Necrosis Factor-alpha; Ubiquinone; Vitamin D; Xanthophylls	2015

Trials

3 trial(s) available for trimetazidine and ubiquinone

Article	Year
[Myocardial cytoprotectors, a reserve therapeutic modality for patients with stable angina of effort]. Klinicheskaia meditsina, 2011, Volume: 89, Issue:4 Topics: Aged; Angina Pectoris; Cytoprotection; Drug Therapy, Combination; Female; Humans; Male; Myocardium; Picolines; Trimetazidine; Ubiquinone	2011
Combination Therapy With Coenzyme Q10 and Trimetazidine in Patients With Acute Viral Myocarditis. Journal of cardiovascular pharmacology, 2016, Volume: 68, Issue:2 Topics: Acute Disease; Adolescent; Adult; Anti-Inflammatory Agents; Antioxidants; Biomarkers; China; Drug Therapy, Combination; Female; Humans; Inflammation Mediators; Male; Myocarditis; Oxidative Stress; Recovery of Function; Stroke Volume; Systole; Time Factors; Treatment Outcome; Trimetazidine; Troponin; Ubiquinone; Ventricular Function, Left; Young Adult	2016
Coenzyme Q10 combined with trimetazidine in the prevention of contrast-induced nephropathy in patients with coronary heart disease complicated with renal dysfunction undergoing elective cardiac catheterization: a randomized control study and in vivo study European journal of medical research, 2018, May-18, Volume: 23, Issue:1 Topics: Acute Kidney Injury; Aged; Animals; Antioxidants; Cardiac Catheterization; Contrast Media; Coronary Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Trimetazidine; Ubiquinone	2018

Other Studies

2 other study(ies) available for trimetazidine and ubiquinone

Article	Year
Protective effects of trimetazidine and coenzyme Q10 on cisplatin-induced cardiotoxicity by alleviating oxidative stress and mitochondrial dysfunction. Anatolian journal of cardiology, 2019, Volume: 22, Issue:5 Topics: Animals; Antioxidants; Apoptosis; Cardiotoxicity; Cell Survival; Cisplatin; Drug Therapy, Combination; Mitochondria; Myocytes, Cardiac; Rats; Trimetazidine; Ubiquinone	2019
The cardioprotective role of trimetazidine on cisplatin-induced cardiotoxicity. Anatolian journal of cardiology, 2020, Volume: 23, Issue:2 Topics: Cardiotoxicity; Cisplatin; Humans; Mitochondria; Oxidative Stress; Trimetazidine; Ubiquinone	2020